Keywords: P; phosphorus; ACPM; amended calcium peroxide material; DO; dissolved oxygen; DIP; dissolved inorganic phosphorus; Fe/Al-P; Fe/Al-adsorbed P; Ca-P; Ca-bound P; Res-P; residual phosphorus; Fe; iron; Al; aluminum; Ca; calcium; FDA; fluorescein diacetate; AA
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: 3D; three dimensional; ADSCs; adipose derived stem cells; ALN; alendronate; ALP; alkaline phosphatase; antimiR; anti-microRNA; ASC; acid soluble collagen; BBS; bovine bone substitutes; BG; bioglass; BMP-2; bone morphogenetic protein-2; BMSCs; bone marrow
Keywords: Biomarker; FDA; personalized medicine;
Keywords: CO2; carbondioxide; CS; caesarean section; DES; diethylstilbesterol; FDA; food and drug administration; POD; Pouch of Douglas; Vaginal adenosis; Bartholin's cyst; Diethylstilbesterol; Vaginal adenocarcinoma;
Keywords: FDA; Food and Drug Administration; MHLW; Ministry of Health, Labour and Welfare; PMDA; Pharmaceuticals and Medical Devices Agency;
Keywords: FDA; US Food and Drug Administration; IVC; inferior vena cava; PE; pulmonary embolism;
Keywords: AASM; American Academy of Sleep Medicine; AHI; apnea-hypopnea index; CPAP; continuous positive airway pressure; DEA; Drug Enforcement Agency; FDA; Food and Drug Administration; MDH; Minnesota Department of Health; OSA; obstructive sleep apnea; THC; tetrah
Keywords: cardiac implantable electronic devices; cybersecurity; hacking; remote monitoring; CIED; cardiovascular implantable electronic device; FDA; Food and Drug Administration; IOT; Internet of things;
Keywords: CD; Crohn's disease; CDAI; Crohn's Disease Activity Index; FDA; Food and Drug Administration; IBD; inflammatory bowel disease; PRO; patient-reported outcomes; PROMIS; Patient-Reported Outcomes Measurement Information System; UC; ulcerative colitis;
Keywords: TCM; traditional Chinese medicine; MHD; Ma Huang Decoction; FDA; The Food and Drug Administration; KRB; Krebs Ringer bicarbonate buffer; Traditional Chinese medicine; Ma Huang; Ephedrine; Toxicity;
Keywords: ASC; ambulatory surgery center; CMS; Centers for Medicare and Medicaid Services; FDA; Food and Drug Administration; FTM; Fluid Thyoglycollate Medium; IFU; instructions for use; IUSS; Immediate Use Steam Sterilization; OICS; Ophthalmic Instrument Cleaning
Keywords: ATP; adenosine triphosphate; EGCG; epigallocatechin gallate; ETC; electron transport chain; FDA; food and drug administration; GSH; glutathione; HBA; hydroxybenzoic acid; HCA; hydroxycinnamic acid; mtROS; mitochondrial ROS; OXPHOS; oxidative phosphorylati
Keywords: drug shortages; pediatrics; outpatient; ambulatory medicine; ASHP; American Society of Health-Systems Pharmacists; FDA; Food and Drug Administration; UUDIS; University of Utah Drug Information Service;
Keywords: FDA; Food and Drug Administration; PMDSIA; Pediatric Medical Device Safety and Improvement Act; HDE; Humanitarian Device Exemption; IP; Intellectual Property; SBIR; Small Business Innovation Research; Medical devices; Technological innovations; Pediatrics
Keywords: prostatic neoplasms; high-intensity focused ultrasound ablation; registries; patient outcome assessment; biomedical technology; CRN; coordinated registry network; EPIC-26; Expanded Prostate Cancer Index Composite-26; FDA; Food and Drug Administration; HIF
Keywords: botulism; cost-effectiveness; efficacy; human botulism immune globulin; infant botulism; orphan disease; orphan drug; rare diseases; BIG-IV; Human Botulism Immune Globulin Intravenous; CDPH; California Department of Public Health; FDA; US Food and Drug Ad
Keywords: Antiepileptic drugs; Clinical trials; Efficacy; Placebo response; Treatment effect; FDA;
Keywords: 5â²AMP; 5â² adenosine monophosphate; ADO; adenosine; DSAs; anti-donor specific antibodies; APC; antigen-presenting cell; CXCL-9; chemokine (C-X-C motif) ligand 9; cAMP; cyclic adenosine monophosphate; CTLA4; cytotoxic T-lymphocyte associated protein 4;
Keywords: FDA; Food and Drug Administration; GERD; gastroesophageal reflux disease; GI; gastrointestinal; HRQL; health-related quality of life; PRO; patient-reported outcome; PROMIS; Patient-Reported Outcomes Measurement Information System;
Keywords: ALA; aminolevulinic acid; CT; computerized tomography; EPR; enhanced permeability and retention; FDA; Food and Drug Administration; FRET; Föster (fluorescence) resonance energy transfer; gGlu; γ-glutamyl; GGT; γ-glutamyltransferase; HMRG; hydroxymethyl
Keywords: WHO; World Health Organization; FDA; Food and Drug Administration; NIH; The National Institutes of Health; AMA; The American Medical Association; CMA; The Canadian Medical Association; T2DM; Type 2 Diabetes Mellitus; α-MSHl; Alpha-melanocyte stimulatory
Keywords: Cancer; Personalized medicine; Tumour microenvironment; Immunobiology; Targeted therapy; Pharmacogenetics; SmPC (alias SPC); summary of product characteristics; IBD; inflammatory bowel disease; ADCC; antibody-dependent cell-mediated cytotoxicity; CDC; com
Keywords: CMS; Centers for Medicare & Medicaid Services; FDA; Food and Drug Administration; HCAHPS; Hospital Consumer Assessment of Healthcare Providers and Systems; IOM; Institute of Medicine;
Keywords: AKI; acute kidney injury; BMD; bone mineral density; CAP; community-acquired pneumonia; CDI; Clostridium difficile infection; CKD; chronic kidney disease; FDA; Food and Drug Administration; NSAID; nonsteroidal anti-inflammatory drug; OR; odds ratio; PPI;
Keywords: Industry 4.0; In silico; Computer model; Digital twin; Tissue engineering; ATMP; Advanced Therapeutic Medicinal Product; ASME; American Society of Mechanical Engineers; CAD-CAM; Computer Aided Design - Computer Aided Manufacturing; cBiT; compendium for
Keywords: FDA; food and drug administration; VNS; vagus nerve stimulation; ILAE; international league against epilepsy; MRI; magnetic resonance imaging; NR; non-responder; R; responder; 90R; 90% responder; DBS; deep brain stimulation; Epilepsy; Vagus nerve stimulat
Keywords: Taste; Sweet; Diet; Pregnancy; Sucrose; Sucralose; FDA; Food and Drug Administration; USA; United States of America; ADI; Acceptable Daily Intake; ace-K; acesulfame-K; T1R2; (taste 1 receptor 2); T1R3; (taste 1 receptor 3); HED; human equivalent dose; NHA
Keywords: Drug-induced liver injury; Hepatotoxicity; Gender differences; Drug property; Spontaneous adverse event reporting system; Liver events, and pharmacovigilance; DILI; drug-induced liver injury; DILIN; drug-induced liver injury network; HC; hepatocellular; C
Keywords: Alpha linolenic acid; Developmental toxicity; Diacylglycerol oil; Flaxseed oil; Food ingredient; Teratology; AA; arachidonic acid; ALA; alpha-linolenic acid; DAG; diacylglycerol; EPA; eicosapentaenoic acid; FDA; Food and Drug Administration; GD; gestation
Keywords: AD; atopic dermatitis; BEEP; Barrier Enhancement for Eczema Prevention; BPA; bisphenol A; CDC; Center for Disease Control and Prevention; DBP; vitamin D binding protein; IL; interleukin; Ig; immunoglobulin; FLG; filaggrin; FDA; Food and Drug Administratio
Keywords: Cancer treatment; Work productivity; Healthcare utilization; Measuring value; CCAE; Commercial Claims and Encounters; FDA; US Food and Drug Administration; HPM; Health and Productivity Management; NCI; National Cancer Institute; SD; Short-Term Disability
Keywords: Ni; Nickel; SBX; Sodium Butyl Xanthate; TOC; Total Organic Carbon; FDA; Fluorescein Diacetate Hydrolase; SA; Sucrase; N; Nitrogen; K; Potassium; P; Phosphorus; Combined pollution; Inhibitory ratio; Growth rate constant; Fluorescein diacetate hydrolase; Su
Keywords: Food allergy; Precautionary allergen; Risk assessment; Peanut; Nuts; Mandatory labeling; VITAL; CFR; Code of Federal Regulations; EU; European Union; FALCPA; Food Allergen Labeling and Consumer Protection Act; FDA; Food and Drug Administration; GMP; Good
Keywords: Eosinophilia; Hypereosinophilic syndromes; Diagnosis; Testing; Treatment; AEC; Absolute eosinophil count; CBC; Complete blood cell count; CT; Computed tomography; EGPA; Eosinophilic granulomatosis with polyangiitis; FDA; Food and Drug Administration; HES;
Keywords: Clinical trial; Pilot; Training concept; Pharmacokinetic; Pharmacodynamic; Feasibility; ACE; Angiotensin-converting-enzyme; Cmax; maximum serum concentration; ELISA; Enzyme-linked immunosorbent assay; EMA; European Medicines Agency; EU; European Union; FD
Keywords: AD; Alzheimer's disease; ALS; amyotrophic lateral sclerosis; CNS; central nervous system; D.W; distilled water; DMEM; Dulbecco's modified Eagle's medium; DMSO; dimethyl sulfoxide; dPC12; differentiated-PC12; FDA; U.S. Food and Drug Administration; GC-MS
Keywords: pharmacokinetics; obesity; pediatrics; proton pump inhibitors; AE; Adverse event; AUC; Area under the concentration time curve; AUCinf; AUC from time zero to infinity; AUClast; AUC from time zero to the time of the last measurable concentration; BMI; Body
Keywords: prostatic neoplasms; United States Food and Drug Administration; patient preference; clinical decision making; equipment and supplies; AS; active surveillance; BOO; bladder outlet obstruction; FDA; Food and Drug Administration; HIFU; high intensity focuse
Keywords: Central nervous system; Craniotomy; Crohn disease; Lymphoma; Multiple sclerosis; Natalizumab; Tsyabri; EBV; Epstein-Barr virus; FDA; Food and Drug Administration; HHV; Human herpesvirus; HIV; Human immunodeficiency virus; Ig; Immunoglobulin; LPD; Lymphopr
Keywords: APC; allophycocyanin; ANOVA; analysis of variance; BBB; blood brain barrier; CNS; Central Nervous System; CD; cluster of differentiation; FCXM; flow cytometry cross match; FITC; fluorescein; FDA; food and drug administration; GLAST; glutamate aspartate tr
Keywords: CLIA; Clinical Laboratory Improvement Act; DTC; direct-to-consumer; FDA; US Food and Drug Administration; GAO; US Government Accountability Office; GHR; genetic health risk;
Keywords: Bronchodilator agents; Electrocardiography; GFF MDI; Pulmonary disease; Chronic obstructive; Holter monitoring; QT prolongation; AE; adverse event; AV; atrioventricular; BID; twice daily; BMI; body mass index; bpm; beats per minute; CI; confidence interva
Keywords: qCO2; metabolic quotient; TN; total nitrogen; eP; extractable phosphorus; SOC; soil organic carbon; AP; acid phosphatase; FDA; fluorescein diacetate; MBC; microbial biomass carbon; 18S; fungal rDNA copies; 16S; bacterial rDNA copies; F:B; fungal:bacterial
Keywords: Post-marketing surveillance; Vaccine safety; Global Vaccine Safety Initiative (GVSI); Adverse events following immunization (AEFI); AEFI; adverse events following immunization; AM; aseptic meningitis; CI; Confidence Interval; CSF; cerebrospinal fluid; EMC
Keywords: GRAS; Generally Recognized As Safe; FDA; Food and Drug Administration; SpPC; Spirulina protein concentrate; SpPI; Spirulina protein isolate; Td; thermal denaturation temperature; Protein concentrate; Protein extraction; Protein isolate; Spirulina;
Keywords: ANOVA; Analysis of variance; AUC; area under the curve; BBP; benzylbutylphthalate; CS; calibration standard; CV; coefficient of variation; DBP; di-n-butyl phthalate; DEHP; di(2-ethylhexyl) phthalate; DMSO; dimethyl sulphoxide; Dv; derivatization yield; ED
Keywords: LOD; limit of detection; LLOQ; lower limit of quantification; THS; Tobacco Heating System; FDA; Food and Drug Administration; DNPH; 2,4-dinitrophenylhydrazine; HPHC; Harmful and potentially harmful components; HPLC; High Performance Liquid Chromatography;
Keywords: Confocal laser scanning microscopy; Saliva; Dental plaque; Antimicrobial agents; Dental caries; Periodontal disease; MBE; magnolia bark extract; LAE; ethyl-lauroyl-arginate; CHX; chlorhexidine; GRAS; generally recognized as safe; FDA; food and drugs admin
Keywords: Signaling; Event study; Market model; Pharmaceuticals; FDA; Incremental information;
Keywords: PSO; Particle Swarm Optimization; FF; Firefly; FPR; False Positive Rate; FNR; False Negative Rate; NPV; Negative Predictive Value; FDR; False Discovery Rate; MCC; Mathews correlation coefficient; SER; Speech Emotion/Stress Recognition; HCI; Human-Computer